Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Sunday share tips: Eden Research, Lok'nStore
(Sharecast News) - The Financial Mail on Sunday's Midas column told readers that shares of Eden Research should more than quintuple in price as it reaps the fruits of its "huge" progress in recent times. Among the milestones reached by the plant-based pest control outfit was growing acceptance among regulators worldwide for Mevalone, its solution against fungal disease in fruit and vegetables.
In just the past six weeks, Mevalone had been greenlighted by regulators in Poland, New Zealand, Florida and California, which should drive sales further.
Another product, Cedroz, against root knot nematodes had been garnering more approvals from watchdogs.
And during the preceding week the company filed for EU approval for Ecovelex, which keeps birds from pecking on crop seeds.
Ecovelex may even gain emergency approval, which would allow its use for next year's harvest.
All of the above was expected to lift the company's bottom line out of the red and into the black over the next couple of years.
In parallel, Eden was researching insecticide treatments that didn't use micro-plastics.
"Eden's plant-based pesticides allow crops, fruit and vegetables to grow and mature unencumbered by disease or synthetic treatments. At 3.65p, the shares are a buy."
The Sunday Times's Lucy Tobin tipped shares of Lok'nStore to readers, highlighting the self-storage group's growth plans and cash pile as reasons to buy in.
She also spied the potential for a bid from one of its larger rivals, Big Yellow or Safestore.
Same-store revenues had jumped by 11% to £13m over the over the six months ending in February, yet its shares had come by 10% over the preceding 12 months.
Admittedly, the shares were changing hands on 29 times their estimated 2023 earnings.
But 11 more stores, on top of its 40 existing ones, were in the pipeline and would add about 50% more total space.
Four more stores were set to open by the end of the next financial year.
The company also had £40.3m of cash on its balance sheet, of which some would be funelled into its pipeline.
Tobin also called attention to the business's conservative management under its boss, Andrew Jacobs.
"As retail and office real estate markets adapt to big structural changes, self- storage continues to grow - and with valuable pricing power in the current inflationary environment," she said.
"Space is becoming an ever-more precious commodity; buy in to Lok'nStore."
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.